vitamin b12 and mic injections Buy B12/MIC Shots Online MIC+B12 Compounded $150 | 60-day

FDA rejection and regulatory status Development timeline: 2000s: Developed for Parkinson's/Alzheimer's 2008: Phase 2 obesity trials (successful) 2010: Phase 3 trials initiated 2010: Development halted due to safety concerns 2012: FDA rejected obesity indication Present: No approved indication anywhere Why FDA rejected: Cardiovascular safety concerns primary reason Increased heart rate and blood pressure Risk-benefit ratio unfavorable Safer alternatives available ( GLP-1 agonists ) Development company abandoned pursuit No current path to approval Regulatory status by country: Current legal classification: Not a controlled substance (not scheduled) Not approved for any human use Sold as "research chemical" only "Not for human consumption" labels Legal gray area (enforcement rare) See are peptides legal guide at SeekPeptides

Over 750 years of history in the city center of Frankfurt (Oder) await your visit

For researchers, this means careful planning and strict adherence to storage protocols, aspects our team is always ready to advise on

This bypasses the digestive system, which can be helpful for people with B12 deficiency caused by absorption issues